Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

Terminalcare Support Institute, Inc.

(TSE/TYO:7362)

Select Model

Rating:48Neutral

Price Target:JPY 860.00▲(1.18% Upside)

Action:reiterated

Date:09/11/26

The overall score of 48 reflects a company under significant financial stress. The primary drag is the poor financial performance, characterized by declining profitability, high and increasing leverage, and persistent negative free cash flow. While the stock shows some mild technical strength and a low P/E ratio, these factors are insufficient to offset the fundamental risks. The low P/E ratio is likely a reflection of the market's concern over the company's deteriorating earnings power and strained balance sheet.

Positive Factors

Consistent Revenue GrowthRevenue growth has been consistent from 2020 through 2025, indicating continued expansion of sales rather than reliance on a single reporting period. If maintained, this top-line momentum can support operating scale and provide a base for restoring profitability over coming quarters.

Negative Factors

Margin CompressionFalling gross and overall profit margins, combined with the sharp 2025 operating-profit decline, weaken confidence in the durability of current earnings. Unless profitability recovers, additional revenue may translate into less operating cash and provide limited support for deleveraging.

Terminalcare Support Institute, Inc. (7362) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 1.30B
Dividend Yield: ―
Average Volume (3M): 1,356
Price to Earnings (P/E): 8.9
Beta (1Y): 0.42
Revenue Growth: 14.48%
EPS Growth: 71.76%
Country: Japan
Employees: 511
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description

Terminalcare Support Institute Inc., established in 2010 and based in Kyoto, Japan, specializes in offering a comprehensive suite of eldercare services throughout Japan. These services encompass in-home care, preventative health initiatives, direct h...

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary

Financial performance is severely strained. Revenue growth has slowed to 2.1%, while margins have deteriorated significantly with net margin at 1.7% and EBIT margin at 0.7%. Net income has declined for three consecutive years. The balance sheet shows escalating leverage with a debt-to-equity ratio of 2.53, and free cash flow has been negative for three straight years, reaching -¥691M. The operating cash flow coverage ratio is a low 0.21, indicating limited capacity to service debt.

Income Statement

28Negative

Balance Sheet

30Negative

Cash Flow

22Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	5.48B	4.89B	4.71B	4.25B	4.10B	3.40B
Gross Profit	767.60M	626.27M	664.67M	646.76M	685.84M	599.50M
EBITDA	348.70M	205.09M	250.59M	196.83M	262.62M	247.27M
Net Income	144.83M	81.97M	113.77M	126.67M	157.54M	138.03M
Balance Sheet
Total Assets	5.96B	5.81B	4.80B	4.09B	3.05B	2.89B
Cash, Cash Equivalents and Short-Term Investments	829.14M	1.19B	1.13B	1.38B	1.09B	874.72M
Total Debt	3.67B	3.58B	2.81B	2.26B	1.22B	1.43B
Total Liabilities	4.48B	4.39B	3.49B	2.90B	1.96B	1.96B
Stockholders Equity	1.48B	1.41B	1.31B	1.19B	1.08B	927.37M
Cash Flow
Free Cash Flow	0	-691.25M	-780.73M	-562.25M	317.64M	-56.66M
Operating Cash Flow	0	287.23M	304.51M	238.18M	812.73M	462.19M
Investing Cash Flow	0	-1.01B	-1.10B	-836.33M	-510.68M	-523.54M
Financing Cash Flow	0	771.09M	545.64M	892.46M	-90.11M	523.02M

Terminalcare Support Institute, Inc. Technical Analysis

Technical Analysis SentimentNeutral

Last Price850.00

Price Trends

50DMA865.56Negative

100DMA862.31Negative

200DMA833.25Positive

Market Momentum

MACD-5.68Negative

RSI44.42Neutral

STOCH74.77Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Neutral. The current price of 850.00 is below the 20-day moving average (MA) of 855.55, below the 50-day MA of 865.56, and above the 200-day MA of 833.25, indicating a neutral trend. The MACD of -5.68 indicates Negative momentum. The RSI at 44.42 is Neutral, neither overbought nor oversold. The STOCH value of 74.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

JP:7362 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:9220	73Outperform	JPY 3.19B	7.21	―	3.29%	5.48%	13.46%
JP:2373	57Neutral	JPY 5.26B	18.40	―	4.35%	4.76%	-52.55%
JP:2425	56Neutral	JPY 2.50B	29.59	―	3.34%	-5.72%	-73.78%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:7362	48Neutral	JPY 1.30B	8.93	―	―	14.48%	71.76%
JP:7061	46Neutral	JPY 3.90B	11.78	―	5.43%	14.91%	-39.00%

* Healthcare Sector Average

Performance Comparison

JP:7362 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:7362	Terminalcare Support Institute, Inc.	850.00	30.03	3.66%
JP:2373	Care Twentyone Corporation	391.00	-67.03	-14.63%
JP:2425	Care Service Co., Ltd.	658.00	-120.64	-15.49%
JP:7061	Japan Hospice Holdings Inc.	460.00	-863.95	-65.26%
JP:9220	FB CARE SERVICE CO.,LTD.	1308.00	86.90	7.12%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 11, 2026

Terminalcare Support Institute, Inc. AI Stock Analysis